Predictors of premature clopidogrel discontinuation within 30 days of successful coronary artery stenting
| Autor: | Cayan Cakir, Cem Nazli, Oktay Ergene, Haci Ates, Barış Kılıçaslan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
lcsh:Diseases of the circulatory (Cardiovascular) system
medicine.medical_specialty business.industry medicine.medical_treatment Mortality rate Coronary stenting Stent Clopidogrel mortality Discontinuation Surgery medicine.anatomical_structure lcsh:RC666-701 Coronary stent Medicine stent cardiovascular diseases Stent thrombosis Cardiology and Cardiovascular Medicine business circulatory and respiratory physiology medicine.drug Artery |
| Zdroj: | International Journal of the Cardiovascular Academy, Vol 4, Iss 1, Pp 1-5 (2018) |
| Popis: | Objective: We aimed to determine the prevalence, predictors, and mortality rate of premature clopidogrel discontinuation within 30 days of successful coronary stenting. Methods: All consecutive patients who underwent successful coronary stent implantation at our hospital between December 2006 and December 2007 were prospectively included in this study. Patients were interviewed by telephone 30 days after stent implantation. Premature clopidogrel discontinuation was defined as follows: patients who did not continue clopidogrel after discharge were defined as “never used” and patients who received clopidogrel for |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|